医学
重症监护医学
疾病
梅德林
临床试验
耐火材料(行星科学)
安全概况
慢性病
生活质量(医疗保健)
系统回顾
作者
Kristin Rathje,Nico Gagelmann,Silke Heidenreich,Johanna Richter,Franziska E. Marquard,Radwan Massoud,Evgeny Klyuchnikov,Catherina Lueck,Ina Rudolph,Francis Ayuk
标识
DOI:10.1016/j.jtct.2025.11.019
摘要
Belumosudil demonstrates promising efficacy and a favorable safety profile in refractory cGvHD. Our findings support further investigation in earlier treatment and disease course.
科研通智能强力驱动
Strongly Powered by AbleSci AI